Table A4.
Cross-Tabulation of Week-1 v Week-8 Metabolic Response
| Week-1 PET Response | Week-8 PET Response |
||||
|---|---|---|---|---|---|
| PMR | SMD | PMD | Unknown | Total | |
| Cohort 1 | |||||
| PMR | 24 | 1 | 1 | 2 | 28 |
| SMD | 3 | 1 | 3 | 2 | 9 |
| PMD | 0 | 1 | 0 | 1 | 2 |
| Unknown | 0 | 0 | 0 | 1 | 1 |
| Total | 27 | 3 | 4 | 6 | 40 |
| Cohort 2 | |||||
| PMR | 16 | 5 | 0 | 0 | 21 |
| SMD | 2 | 16 | 2 | 2 | 22 |
| PMD | 0 | 0 | 0 | 0 | 0 |
| Unknown | 0 | 1 | 0 | 1 | 2 |
| Total | 18 | 22 | 2 | 3 | 45 |
NOTE. Seventy-five patients (cohort 1, 34; cohort 2, 41) were evaluable for comparison of week-1 v week-8 metabolic response by [18F]fluorodeoxyglucose positron emission tomography/computed tomography according to European Organisation for Research and Treatment of Cancer criteria.
Abbreviations: PET, positron emission tomography; PMD, progressive metabolic disease; PMR, partial metabolic response; SMD, stable metabolic disease.